Company / Current Assets
IOVANCE BIOTHERAPEUTICS, INC. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$442.7M
FY2025
5-year range
$307.8M / $508.0M
FY2021-FY2025
Trend
-3.1%
vs FY2024
Sector context
#125 of 213
Health Care
What the data says
At $443M, IOVANCE BIOTHERAPEUTICS, INC.'s current assets ranks #125 of 213 in the Health Care sector. Current Assets has fluctuated over the past 10 years, ranging from $149M in FY2017 to $636M in FY2020.
Based on SEC 10-K filings.
$443M in FY2025 with a 5-year CAGR of -7.0%.
Improved from $308M to $443M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -2.6%
- 5-Year CAGR
- -7.0%
- 10-Year CAGR
- -
Sector benchmark
#125 of 213 in Health CareTop 59% of 213This company $442.7M Sector average $2.5B
▼
-82.5% below sector average
Key checks
Key Insights
- 5-year CAGR of -7.0%, indicating a declining trend.
- In FY2025, current assets decreased 3.1% year-over-year.
- Ranks #125 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $442.7M | -3.1% |
| FY2024 | $457.0M | +48.5% |
| FY2023 | $307.8M | -35.7% |
| FY2022 | $479.1M | -5.7% |
| FY2021 | $508.0M | -20.1% |
| FY2020 | $636.1M | +101.0% |
| FY2019 | $316.5M | -33.4% |
| FY2018 | $475.4M | +218.4% |
| FY2017 | $149.3M | -11.9% |
| FY2016 | $169.5M | +63.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026